Table of Content

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet by End-User
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Advancements in Point-of-Care Diagnostics
3.1.1.2. Rising Aging Population and Chronic Diseases
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Stringent Regulatory Requirements
3.1.2.2. High Costs of Advanced Diagnostics
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Expansion of Home-Based Testing
3.1.3.2. Advancements in Digital and Mobile Health Integration
3.1.3.3. XX
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.6. Porter’s Five Forces Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. Japan Point-of-Care Diagnostics Market, By Product
5.1. Introduction
5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product
5.1.2. Market Attractiveness Index, By Product
5.2. Infectious Disease Testing Products*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Blood Glucose Products
5.4. Blood Gas & Electrolyte Products
5.5. Urinalysis Products
5.6. Hemoatology Testing Products
5.7. Pregnancy and Fertility Testing Products
5.8. Tumor/Cancer Profiling Products
5.9. Drug-of-Abuse Products
5.10. Others
6. Japan Point-of-Care Diagnostics Market, By Technology
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Lateral Flow Assays*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Immunoassays
6.4. Molecular Diagnostics
6.5. Microfluidics
6.6. Others
7. Japan Point-of-Care Diagnostics Market, By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Infectious Diseases*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiology
7.4. Oncology
7.5. Endocrinology
7.6. Hematology
7.7. Neurology
7.8. Drug Testing
7.9. Others
8. Japan Point-of-Care Diagnostics Market, By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Laboratories
8.4. Home Care Settings
8.5. Ambulatory Surgery Centers (ASCs)
9. Competitive Landscape and Market Positioning
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. Company Profiles
10.1. Becton, Dickinson and Company (BD)*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Quidel Corporation
10.3. QIAGEN
10.4. Trinity Biotech
10.5. BioM?rieux SA
10.6. Roche Diagnostics
10.7. Siemens Healthineers
10.8. Abbott Laboratories
10.9. Danaher Corporation
10.10. SEKISUI MEDICAL CO., LTD.
LIST NOT EXHAUSTIVE
11. Assumptions and Research Methodology
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. Appendix
12.1. About Us and Services
12.2. Contact Us